5. Diabetes Flashcards
What is prediabetes?
Blood sugars are higher than usual, but not high enough to be diagnosed with T2DM.
Are at a high risk of developing T2DM.
(Not a clinical term recognised by WHO → Starting to be used more by healthcare professionals and in the media to describe people who are at high risk of T2DM.
What are other names for prediabetes?
Borderline Diabetes
Impaired Glucose Regulation (IGR)
Non-diabetic hyperglycaemia
Impaired fasting glucose (IFG) together with Impaired Glucose Tolerance (IGT)
What are the symptoms of prediabetes?
Don’t have any symptoms.
If you start to have any symptoms of T2DM it means you have probably already developed it.
List modifiable factors that increase risk of diabetes
Smoking
History of high BP
Being overweight, especially with centripetal obesity
Sedentary lifestyle (physically inactive → Not doing enough physical activity; sedentary → sitting or lying down for long periods).
Alcohol
List non-modifiable factors that increase risk of diabetes
Older age; more at risk of white and over 40 OR over 25 and Afro-Caribbean, Black African or South Asian.
Having a parent, brother, sister or child with diabetes
Polycystic Ovary Syndrome (PCOS associated with insulin resistance)
Mental health conditions (e.g. schizophrenia, bipolar disorder, depression)
Antipsychotic medication (risk is quite low)
Roughly what % of people who have diabetes have T2D?
90%
(Can come on slowly (Insidious onset), usually over the age of 40. Signs may not be obvious or there may be no signs at all, therefore it might be up to 10 years before diagnosis
What is the NHS diabetes prevention programme?
Joint commitment from NHS England, Public Health England and Diabetes UK, to deliver at scale, evidence based behavioural interventions for individuals identified as being at high risk of developing T2MD.
Why implement the NHS diabetes prevention programme?
Many cases of T2DM are preventable.
Strong international evidence that behavioural interventions can significantly reduce risk of developing condition, through reducing weight, increasing physical activity and improving the diet of those at high risk
Diabetes treatment → 10% of annual NHS budget.
What are the aims of the programme?
Long-term:
- Reduce incidence of T2DM
- Reduce incidence of complications associated with diabetes- heart, stroke, kidney, eye and foot problems related to diabetes
- Reduce health inequalities associated with incidence of diabetes
What is the intervention?
NHS DPP has 3 core goals:
- Achieving a healthy weight
- Achievement of dietary recommendations
- Achievement of CMO physical activity
Who is eligible for the NHS DPP?
Individuals eligible for inclusion have ‘non-diabetic hyperglycaemia’ [NDH] defined as → HbA1c 42-47 mmol/mol or a fasting plasma glucose (FPG) of 5.5-6.9 mmol/L.
Blood result indicating NDH must be within the last 12 months to be eligible for referral and only the most recent blood reading can be used.
Only individuals 18+
What are the referral routes into the programme?
- Those who have already been identified as having an appropriately HbA1c 42 – 47 mmol/mol elevated risk level (HbA1c or FPG) in the past and who have been included on a register of patients with high HbA1c or FPG
- The NHS Health Check programme, which is currently available for FPG 5.5 - 6.9 mmol/l individuals between 40 and 74; NHS Health Checks includes a diabetes filter, those identified to be at high risk through stage 1 of the filter are offered a blood test to confirm risk
- Those who are identified with non-diabetic hyperglycaemia through opportunistic assessment as part of routine clinical care
Which cells release insulin and which release glucagon?
Beta-cells → Insulin → Converts glucose into glycogen.
Alpha-cells → Glucagon → Converts glycogen into glucose.
What are the core defects in T2DM?
Insulin resistance in muscle and liver
Impaired insulin secretion by the pancreatic Beta-cells
List all the causes of hyperglycaemia and explain the mechanism of each (check notion)
- Increased glucose Reabsorption
- Decreased glucose Uptake
- Increased Lipolysis
- Inflammation
- NT Dysfunction
- Increased Glucagon secretion
- Increased Hepatic glucose production
- Decreased Insulin secretion
- Vascular insulin resistance
- Decreased insulin Effect